Translate this page into:
Post Diuretic [18F]-Fluorodeoxyglucose Pet Scan for Detection of Residual/Recurrent Bladder Tumor
Correspondence to: Brig SS Anand, Consultant & H.O.D Dept. of Nuclear Medicine, Army Hospital (R&R), Delhi Cantt, New Delhi 110010 Ph: 011-23338173, 23338171 Email: drssanand@gmail.com
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Conventionally 18F-Fluorodeoxyglucose (FDG) Positron emission tomography (PET) has been considered to be of limited value for detection of bladder cancer because of interference by the FDG excreted in urine. An 83 year old male with urothelial carcinoma of the bladder underwent trans-urethral resection of bladder tumor (TURBT) and was post operatively advised FDG PET scan for assessing the residual locoregional disease and distant spread if any. We carried out a dual phase PET-CT scan with addition of intravenous frusemide and oral hydration. This modified scanning technique achieved adequate washout of urinary FDG and was successful in demonstrating the residual bladder tumor and its multi focal nature.
